Back to Market Feed

Product Information

MOMETASONE FUROATE 50 MCG SPRY is a generic product labeled by Aurobindo Pharma Limited, priced at $1.5899 per GM under NDC 59651040217. Its NADAC has been published 107 times since Aug 7, 2024.

FDA first approved this application on Mar 18, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MOMETASONE FUROATE 50 MCG SPRY

MOMETASONE FUROATE MONOHYDRATE
$1.5899per GM

Strength

50 ug/1

NDC

59651040217

Classification

Generic

Dosage Form

SPRAY, METERED

Route

NASAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA215878

FDA Approved

3/18/2024

TE Code

AB

On Market Since

3/18/2024

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for MOMETASONE FUROATE 50 MCG SPRY has been published 107 times since Aug 7, 2024, and over the history we have for it it has declined 27.1%. The table below summarizes its recorded NADAC range and movement.

Current price$1.5899 per GM
All-time high$2.1803 (Aug 14, 2024)
All-time low$1.5899 (Aug 19, 2026)
52-week high$1.7874
52-week low$1.5899
Median price$1.7357
Average price$1.7519
Largest weekly change-14.3% (Nov 20, 2024)
Weeks tracked107
Tracking sinceAug 7, 2024

Price History

1W

-1.0%

1M

-1.0%

3M

-1.5%

6M

-5.2%

1Y

-9.1%

3Y

N/A

5Y

N/A

All

-27.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the MOMETASONE FUROATE MONOHYDRATE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

TRIAMCINOLONE 0.1% CREAM
Generic
00168000416•E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.
$0.0247
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
16714098604•NorthStar Rx LLC
$0.0280
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
21922006230•Encube Ethicals, Inc.
$0.0280
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
33342032954•Macleods Pharmaceuticals Limited
$0.0280
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
45802006405•Padagis Israel Pharmaceuticals Ltd
$0.0280
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
52817081154•TruPharma LLC
$0.0280
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
67877025145•Ascend Laboratories, LLC
$0.0280
per GM
DEXAMETHASONE 0.5 MG/5 ML LIQ
Generic
00054317763•Hikma Pharmaceuticals USA Inc.
$0.0293
per ML
TRIAMCINOLONE 0.1% CREAM
Generic
68462013159•Glenmark Pharmaceuticals Inc., USA
$0.0300
per GM
TRIAMCINOLONE 0.1% OINTMENT
Generic
16714027603•NorthStar Rx LLC
$0.0348
per GM

Frequently asked questions

What is the NADAC price of MOMETASONE FUROATE 50 MCG SPRY?

The current National Average Drug Acquisition Cost (NADAC) for MOMETASONE FUROATE 50 MCG SPRY, manufactured by Aurobindo Pharma Limited, is $1.5899 per GM (NDC 59651040217), effective Aug 19, 2026.

How has the price of MOMETASONE FUROATE 50 MCG SPRY changed over time?

Over the history we have for it, the NADAC for MOMETASONE FUROATE 50 MCG SPRY has declined 27.1%. It has been tracked across 107 weekly CMS publications since Aug 7, 2024.

What are the highest and lowest recorded NADAC prices for MOMETASONE FUROATE 50 MCG SPRY?

Since Aug 7, 2024, the NADAC for MOMETASONE FUROATE 50 MCG SPRY has ranged from a low of $1.5899 (Aug 19, 2026) to a high of $2.1803 (Aug 14, 2024), with a median of $1.7357 per GM.

Are there cheaper alternatives to MOMETASONE FUROATE 50 MCG SPRY?

No other NADAC-published product currently shares the active ingredient and strength of MOMETASONE FUROATE 50 MCG SPRY in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures MOMETASONE FUROATE 50 MCG SPRY?

MOMETASONE FUROATE 50 MCG SPRY (NDC 59651040217) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.